The D355V Mutation Decreases EGR2 Binding to an Element within the Cx32 Promoter

Bellone, 1999, A novel mutation (D305V) in the early growth response 2 gene is associated with severe Charcot–Marie–Tooth type 1 disease, Hum. Mutat., 15, 353, 10.1002/(SICI)1098-1004(199910)14:4<353::AID-HUMU17>3.0.CO;2-4 Brown, 1997, Multiple regulatory elements control transcription of the peripheral myelin protein zero gene, J. Biol. Chem., 272, 28939, 10.1074/jbc.272.46.28939 Choo, 1994, In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence, Nature, 372, 642, 10.1038/372642a0 Ciotti, 2001, Characterisation of a triplex DNA-binding protein encoded by an alternative reading frame of loricrin, Eur. J. Biochem., 268, 225, 10.1046/j.1432-1033.2001.01859.x Lupski, 1991, DNA duplication associated with Charcot–Marie–Tooth disease type 1A, Cell, 66, 219, 10.1016/0092-8674(91)90613-4 Nelis, 1999, Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies, Hum. Mutat., 13, 11, 10.1002/(SICI)1098-1004(1999)13:1<11::AID-HUMU2>3.0.CO;2-A Pareyson, 2000, Cranial nerve involvement in CMT disease type 1 due to early growth response 2 gene mutation, Neurology, 54, 1696, 10.1212/WNL.54.8.1696 Pavletich, 1991, Zinc finger-DNA recognition: Crystal structure of a Zif268-DNA complex at 2.1 A, Science, 252, 809, 10.1126/science.2028256 Raeymaekers, 1991, Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group, Neuromuscul. Disord., 1, 93, 10.1016/0960-8966(91)90055-W Sander, 1998, Charcot–Marie–Tooth disease: Histopathological features of the peripheral myelin protein (PMP22) duplication (CMT1A) and connexin32 mutations (CMTX1), Muscle Nerve, 21, 217, 10.1002/(SICI)1097-4598(199802)21:2<217::AID-MUS9>3.0.CO;2-E Swirnoff, 1995, DNA-binding specificity of NGFI-A and related zinc finger transcription factors, Mol. Cell Biol., 15, 2275, 10.1128/MCB.15.4.2275 Timmerman, 1999, Novel missense mutation in the early growth response 2 gene associated with Dejerine–Sottas syndrome phenotype, Neurology, 52, 1827, 10.1212/WNL.52.9.1827 Topilko, 1994, Krox-20 controls myelination in the peripheral nervous system, Nature, 371, 796, 10.1038/371796a0 Van-Dyke, 1992, Single-step purification of bacterially expressed polypeptides containing an oligo-histidine domain, Gene, 111, 99, 10.1016/0378-1119(92)90608-R Warner, 1998, Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies, Nat. Genet., 18, 382, 10.1038/ng0498-382 Warner, 1999, Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies, Hum. Mol. Genet., 8, 1245, 10.1093/hmg/8.7.1245 Zorick, 1999, Krox-20 controls SCIP expression, cell cycle exit and susceptibility to apoptosis in developing myelinating Schwann cells, Development, 126, 1397, 10.1242/dev.126.7.1397